Internationally, we work very closely with our counterparts on these issues. For example, we work with ICH, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, which is responsible for harmonizing and updating our rules and guidelines for clinical trials.
That's one example.
We’re also part of other international working groups. We’re working with ICMRA, which is the International Coalition of Medicines Regulatory Authorities, an international coalition made up of regulatory bodies, on the issue of data and how we can improve the way we ask big companies to provide us with their data. So we’re working very closely with our partners on the international stage.